Oscar Health (NYSE:OSCR) CFO Richard Scott Blackley Sells 28,869 Shares

Oscar Health, Inc. (NYSE:OSCRGet Free Report) CFO Richard Blackley sold 28,869 shares of the firm’s stock in a transaction on Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total value of $907,930.05. Following the completion of the sale, the chief financial officer owned 1,046,108 shares in the company, valued at approximately $32,900,096.60. This represents a 2.69% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Richard Scott Blackley also recently made the following trade(s):

  • On Tuesday, August 18th, Richard Blackley sold 18,750 shares of Oscar Health stock. The stock was sold at an average price of $31.74, for a total value of $595,125.00.

Oscar Health Trading Up 2.0%

NYSE:OSCR opened at $32.90 on Wednesday. Oscar Health, Inc. has a 1 year low of $10.69 and a 1 year high of $33.55. The stock has a market cap of $10.15 billion, a P/E ratio of 23.50, a P/E/G ratio of 0.66 and a beta of 2.37. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.09 and a current ratio of 1.09. The stock has a 50-day simple moving average of $30.58 and a 200-day simple moving average of $23.01.

Oscar Health (NYSE:OSCRGet Free Report) last issued its earnings results on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.70. The business had revenue of $4.88 billion for the quarter, compared to analyst estimates of $4.73 billion. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.The business’s quarterly revenue was up 70.4% on a year-over-year basis. During the same quarter last year, the company earned ($0.89) EPS. As a group, analysts anticipate that Oscar Health, Inc. will post 1.54 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. GAMMA Investing LLC boosted its holdings in shares of Oscar Health by 32.9% in the second quarter. GAMMA Investing LLC now owns 1,441 shares of the company’s stock valued at $41,000 after acquiring an additional 357 shares during the period. Focus Partners Wealth grew its position in shares of Oscar Health by 1.4% during the third quarter. Focus Partners Wealth now owns 57,787 shares of the company’s stock worth $1,094,000 after acquiring an additional 824 shares during the last quarter. Equitable Holdings Inc. increased its holdings in shares of Oscar Health by 7.0% in the 4th quarter. Equitable Holdings Inc. now owns 12,975 shares of the company’s stock valued at $186,000 after acquiring an additional 850 shares during the period. IFP Advisors Inc increased its holdings in shares of Oscar Health by 69.5% in the 2nd quarter. IFP Advisors Inc now owns 2,139 shares of the company’s stock valued at $61,000 after acquiring an additional 877 shares during the period. Finally, Captrust Financial Advisors raised its position in Oscar Health by 2.0% in the 4th quarter. Captrust Financial Advisors now owns 45,754 shares of the company’s stock valued at $657,000 after purchasing an additional 895 shares during the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on OSCR. Piper Sandler restated an “overweight” rating and set a $36.00 price objective on shares of Oscar Health in a research report on Tuesday, July 28th. UBS Group increased their target price on shares of Oscar Health from $20.00 to $26.00 and gave the company a “neutral” rating in a research report on Friday, August 7th. Robert W. Baird set a $27.00 price target on shares of Oscar Health in a research note on Friday, August 7th. Zacks Research raised shares of Oscar Health from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 6th. Finally, Weiss Ratings upgraded shares of Oscar Health from a “sell (d+)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $26.22.

Get Our Latest Stock Report on Oscar Health

Key Headlines Impacting Oscar Health

Here are the key news stories impacting Oscar Health this week:

  • Neutral Sentiment: Director Mario Schlosser sold 31,422 shares for approximately $988,000 and retained 449,444 shares. Mario Schlosser SEC filing
  • Neutral Sentiment: CFO Richard Blackley sold 28,869 shares valued at roughly $908,000, while continuing to own more than 1.04 million shares. Richard Blackley SEC filing
  • Neutral Sentiment: Other insiders Adam Mcananey, Janet Liang and Chief Accounting Officer Victoria Baltrus sold approximately $642,000 combined. Each sale was also tied to tax obligations and represented only a modest reduction in their respective holdings. Adam Mcananey SEC filing Janet Liang SEC filing Victoria Baltrus SEC filing

About Oscar Health

(Get Free Report)

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.

Featured Articles

Insider Buying and Selling by Quarter for Oscar Health (NYSE:OSCR)

Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.